Democratic Republic of the Congo vs South Sudan: Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology
Democratic Republic of the Congo
1.4%
in 2024
South Sudan
1.7%
in 2024
Democratic Republic of the Congo rank
22nd
South Sudan rank
20th
Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology over time
- Democratic Republic of the Congo
- South Sudan
How they compare
South Sudan currently reports 1.7% against 1.4% in Democratic Republic of the Congo, a difference of 0.3%.
That makes South Sudan's figure about 1.2 times Democratic Republic of the Congo's.
Across all 10 years both countries report, South Sudan has been ahead every year.
Democratic Republic of the Congo ranks 22nd and South Sudan ranks 20th of 246 countries.
South Sudan has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Democratic Republic of the Congo | South Sudan | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 1.5% | 4.2% | 2.7% | South Sudan |
| 2020s | 1.4% | 2.2% | 0.8% | South Sudan |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher prevalence of hepatitis b surface antigen (hbsag), 2026 methodology, Democratic Republic of the Congo or South Sudan?
- South Sudan, at 1.7% against 1.4% in Democratic Republic of the Congo as of 2024.
- What is the difference in prevalence of hepatitis b surface antigen (hbsag), 2026 methodology between Democratic Republic of the Congo and South Sudan?
- 0.3%, with South Sudan ahead.
- How many years of comparable data are there for Democratic Republic of the Congo and South Sudan?
- 10 years are reported by both, from 2015 to 2024.
- How do Democratic Republic of the Congo and South Sudan rank globally for prevalence of hepatitis b surface antigen (hbsag), 2026 methodology?
- Democratic Republic of the Congo ranks 22nd and South Sudan ranks 20th of 246 countries.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.